Bristol-Myers Squibb Co. (NYSE:BMY)

The profitability metrics exhibited varied trends over the observed period. Initial quarters demonstrated generally stable or improving performance, followed by a significant shift in later periods. A notable decline in key profitability indicators occurred between September 2023 and December 2024, before a recovery commenced in the subsequent quarters.

Gross Profit Margin

The gross profit margin experienced a consistent, albeit gradual, decline from 79.62% in March 2022 to 71.08% in December 2024. This downward trend suggests increasing costs of goods sold relative to revenue. However, a slight recovery to 71.08% was observed in December 2025, indicating a potential stabilization or improvement in cost management.

Operating Profit Margin

The operating profit margin initially showed some volatility, increasing from 16.79% to 19.04% through September 2022, then fluctuating around 17-18% through June 2023. A dramatic decrease occurred in the following quarters, reaching -14.30% by March 2024. This substantial decline indicates significant increases in operating expenses or a decrease in revenue. A strong recovery began in March 2025, culminating in 20.75% by December 2025, suggesting successful cost control measures or revenue growth initiatives.

Net Profit Margin

Mirroring the trend in operating profit margin, the net profit margin demonstrated initial stability and growth, peaking at 18.44% in September 2023. A sharp decline followed, with the margin becoming negative at -13.50% in March 2024 and reaching its lowest point at -18.53% in December 2024. Similar to the operating margin, a recovery commenced in March 2025, with the net profit margin reaching 14.64% by December 2025.

Return on Equity (ROE)

ROE exhibited a positive trend through September 2023, increasing from 19.79% to 28.57%. However, it experienced a substantial and negative shift, plummeting to -37.28% by March 2024 and reaching a low of -54.78% in December 2024. This indicates a significant decrease in net income relative to shareholder equity. A strong rebound began in March 2025, with ROE climbing to 38.19% by December 2025, suggesting improved profitability and efficient use of equity.

Return on Assets (ROA)

ROA followed a similar pattern to ROE, increasing from 6.07% to 9.08% through September 2023, then experiencing a sharp decline to -6.21% by March 2024, and a low of -9.66% in December 2024. This suggests a decrease in profitability relative to total assets. A recovery began in March 2025, with ROA reaching 7.83% by December 2025, indicating improved asset utilization and profitability.

The period between March 2024 and December 2024 represents a period of significant financial challenge, as evidenced by the negative values across all profitability ratios. The subsequent recovery in the final quarters suggests successful implementation of corrective measures. The consistent correlation between the trends of these ratios indicates a systemic shift in the company’s financial performance, rather than isolated incidents.

The gross profit margin exhibited a generally declining trend over the observed period, spanning from March 31, 2022, to December 31, 2025. While fluctuations occurred, the overall trajectory indicates decreasing profitability at the gross level. Initial values were relatively stable, followed by a more pronounced decrease, and a slight recovery towards the end of the period.

Initial Period (Mar 31, 2022 – Dec 31, 2022)

The gross profit margin began at 79.62% in March 2022 and experienced a gradual decline to 78.04% by December 2022. This represents a decrease of 1.58 percentage points over four quarters. Revenues also showed some fluctuation during this period, but remained relatively high.

Continued Decline (Mar 31, 2023 – Dec 31, 2023)

The downward trend continued into the first half of 2023, reaching 77.01% in June 2023. A slight recovery was observed in the latter half of 2023, with the margin increasing to 76.24% by December 2023. Revenues experienced a slight decrease during this period.

Significant Drop and Partial Recovery (Mar 31, 2024 – Dec 31, 2025)

A more substantial decrease occurred in the first quarter of 2024, with the gross profit margin falling to 71.08% in December 2024. This represents the lowest point in the observed period. A partial recovery was then noted, with the margin increasing to 71.08% by December 2025. Revenues showed an increase in the first half of 2024, followed by a decrease and then a slight increase again.

Gross Margin Values

The gross margin in US$ millions generally followed the revenue trend, decreasing from 9,177 in March 2022 to 7,530 in December 2024, before increasing to 8,406 in December 2025. This suggests the decline in gross profit margin is not solely attributable to revenue changes, but also to changes in the cost of goods sold.

The observed decline in gross profit margin warrants further investigation to determine the underlying causes. Potential factors could include increased production costs, changes in product mix, pricing pressures, or inefficiencies in the supply chain. The partial recovery in the most recent quarters suggests potential mitigation efforts may be underway, but continued monitoring is recommended.

The operating profit margin exhibited a generally positive trend from the first quarter of 2022 through the fourth quarter of 2023, followed by a significant disruption and subsequent recovery. A detailed examination of the quarterly figures reveals fluctuations and notable shifts in profitability.

Initial Growth Phase (Q1 2022 – Q4 2022)

The operating profit margin began at 16.79% in the first quarter of 2022 and generally increased, peaking at 19.04% in the third quarter of the same year. While a slight decrease was observed in the fourth quarter of 2022, settling at 17.96%, the overall trend during this period indicated improving operational efficiency and profitability.

Continued Stability and Slight Decline (Q1 2023 – Q4 2023)

The first half of 2023 showed relative stability, with the margin fluctuating between 17.29% and 18.13%. A gradual decline was then observed in the latter half of the year, ending at 16.18% in the fourth quarter. This suggests potential emerging pressures on operational profitability.

Significant Disruption (Q1 2024)

The first quarter of 2024 experienced a dramatic and substantial decrease in the operating profit margin, falling to -14.30%. This represents a significant loss and a major deviation from previous performance. Subsequent quarters in 2024 showed a slow recovery, reaching -14.05% in the second quarter, and -15.50% in the third, before improving to 480 in the fourth quarter.

Recovery and Strong Growth (Q1 2025 – Q4 2025)

The operating profit margin demonstrated a strong recovery throughout 2025. It increased from 15.24% in the first quarter to 16.70% in the second, 18.86% in the third, and culminated in a substantial 20.75% in the fourth quarter. This indicates successful implementation of corrective measures or favorable market conditions contributing to improved profitability.

Overall Trend

Despite the significant disruption in the first quarter of 2024, the operating profit margin generally trended upwards over the observed period. The recovery in 2025 was particularly noteworthy, exceeding the levels seen in 2022 and 2023. The substantial negative margin in early 2024 warrants further investigation to understand the underlying causes and ensure the sustainability of the subsequent recovery.

The net profit margin exhibited a generally positive trend from the first quarter of 2022 through the fourth quarter of 2023, followed by a significant disruption and subsequent recovery. Initial observations indicate a period of increasing profitability, followed by substantial losses, and a return towards positive margins.

Overall Trend (2022-2025)

From March 31, 2022, to September 30, 2023, the net profit margin demonstrated consistent growth, increasing from 13.31% to 18.44%. This suggests improving operational efficiency or favorable pricing dynamics during this period. However, a dramatic decline occurred in the subsequent quarters, culminating in a negative net profit margin of -13.50% by March 31, 2024. The margin continued to be negative through the second and third quarters of 2024, reaching a low of -18.53% in September 2024. A recovery began in the fourth quarter of 2024 and continued through the first half of 2025, with the margin reaching 14.64% by June 30, 2025.

Period of Growth (Q1 2022 – Q3 2023)

The period between March 31, 2022, and September 30, 2023, saw a steady increase in the net profit margin. The margin rose from 13.31% to a peak of 18.44%, indicating a strengthening ability to convert revenue into profit. This growth suggests effective cost management or increased revenue relative to costs.

Significant Decline (Q4 2023 – Q3 2024)

A substantial and rapid decline in the net profit margin began in December 2023, continuing through the first three quarters of 2024. The margin fell from 17.83% in December 2023 to -18.53% in September 2024. This sharp decrease is largely attributable to a significant net loss reported in March 2024 (-11,911 US$ in millions), which heavily impacted the margin calculation. The decline suggests a major adverse event, such as substantial one-time costs, a significant decrease in revenue, or a combination of both.

Recovery Phase (Q4 2024 – Q2 2025)

Starting in December 2024, the net profit margin began to recover, moving from -18.53% to 14.64% by June 30, 2025. This recovery indicates that the factors causing the previous decline were addressed or are diminishing in impact. The return to positive and relatively strong margins suggests a successful turnaround in profitability.

Revenue Correlation

While the net profit margin experienced fluctuations, revenues generally remained stable or increased throughout the period. The significant margin decline was not primarily driven by a decrease in revenue, but rather by the substantial net loss in the first quarter of 2024. This suggests that the profitability issue was related to factors impacting net earnings specifically, rather than overall sales performance.

Return on Equity (ROE) exhibited a generally positive trend from the first quarter of 2022 through the fourth quarter of 2023, followed by a significant disruption and subsequent recovery. The period from early 2024 to the end of 2025 demonstrates substantial volatility, ultimately concluding with a return to strong performance.

Initial Growth Phase (Q1 2022 – Q4 2023)

ROE began at 19.79% in the first quarter of 2022 and steadily increased, reaching a peak of 28.57% in the third quarter of 2023. This indicates improving profitability relative to shareholder equity during this period. The increase suggests the company was becoming more efficient in generating profits from its equity base. The fourth quarter of 2023 saw a slight decrease to 27.27%, but remained at a strong level.

Significant Decline (Q1 2024 – Q4 2024)

The first quarter of 2024 marked a dramatic shift, with ROE plummeting to -37.28%. This decline continued through the remainder of the year, reaching a low of -54.78% in the fourth quarter. This substantial negative ROE is primarily attributable to a significant net loss reported in the first quarter of 2024, coupled with a decrease in total shareholders’ equity. The negative values indicate that the company was not generating profits from shareholder investments during this period, and was, in fact, experiencing losses relative to equity.

Recovery and Subsequent Performance (Q1 2025 – Q4 2025)

A strong recovery commenced in the first quarter of 2025, with ROE rebounding to 31.16%. This upward trend continued, reaching 38.19% by the fourth quarter of 2025. This recovery is driven by a return to net earnings and a stabilization, and then slight increase, in total shareholders’ equity. The final ROE value suggests a substantial improvement in profitability relative to equity compared to the prior year.

Overall Volatility

The period under review demonstrates considerable volatility in ROE. While a clear upward trend was present in the initial phase, the subsequent sharp decline and recovery highlight potential underlying business challenges and/or significant one-time events impacting the company’s financial performance. The substantial swing in ROE warrants further investigation into the factors driving these fluctuations.

The Return on Assets (ROA) exhibited a generally positive trend from March 31, 2022, through September 30, 2023, followed by a significant disruption and subsequent recovery. Initial observations indicate a period of increasing profitability relative to asset base, then a substantial decline, and finally, a return towards positive performance.

Initial Growth Phase (Mar 31, 2022 – Sep 30, 2023)

From March 31, 2022, to September 30, 2023, ROA increased consistently, moving from 6.07% to a peak of 9.08%. This suggests improving efficiency in utilizing assets to generate earnings during this period. The increase indicates a strengthening relationship between net earnings and the total asset base.

Significant Decline (Dec 31, 2023 – Mar 31, 2024)

A dramatic decrease in ROA occurred in December 31, 2023, and continued through March 31, 2024. The ratio fell to -6.21% in December 2023 and further to -6.91% in June 2024, reaching a low of -9.66% in December 2024. This substantial decline is primarily attributable to a large net loss reported in March 2024, while total assets remained relatively stable. The negative ROA indicates that the company’s assets were not generating sufficient earnings during this timeframe, and in fact, resulted in a loss relative to the asset base.

Recovery Phase (Mar 31, 2025 – Dec 31, 2025)

Beginning with the quarter ending March 31, 2025, ROA began to recover. The ratio increased to 5.86% in March 2025, 5.33% in June 2025, 6.23% in September 2025, and reached 7.83% by December 31, 2025. This recovery is linked to a return to positive net earnings, coupled with a slight decrease in total assets. The upward trend suggests a restoration of profitability and improved asset utilization.

Overall Trend

The period under review demonstrates significant volatility in ROA. While the initial and final portions of the period show positive performance and growth, the substantial decline in late 2023 and throughout 2024 represents a critical period of underperformance. The recovery in the latter part of 2025 indicates a potential stabilization of profitability, but continued monitoring is warranted to assess the sustainability of this trend.